ArticleNPJ precision oncology2024
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition.
Daniel S Lenchner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it